NT219
24-0689.cc
Phase 2 small_molecule active
Quick answer
NT219 for Head and Neck Cancer is a Phase 2 program (small_molecule) at PURPLE BIOTECH LTD. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PURPLE BIOTECH LTD.
- Indication
- Head and Neck Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active